Product Images Terbinafine Hydrochloride

This text appears to be a chart detailing the adverse events of a drug called Lamisit compared to a placebo. Common side effects such as headaches, gastrointestinal symptoms (diarrhea, dyspepsia, abdominal pain, nausea, flatulence), and dermatological symptoms (rash, pruritus, urticaria) are listed. Liver enzyme abnormalities are also reported, with a note that they are 22 times the upper limit of the normal range.*

This is a list of symptoms that may be experienced by an individual. The symptoms include nausea, stomach pain (abdominal pain), rash, headache, vomiting, dizziness, and frequent urination. These symptoms can be associated with a variety of medical conditions and it is important to seek medical advice if they persist or worsen.*

This text describes a list of symptoms and signs that are commonly associated with liver problems, such as hepatitis or liver cancer. These symptoms include nausea, vomiting, poor appetite, tiredness, upper right abdominal pain, yellowing of the skin or eyes (i.e., jaundice), dark urine, and pale or light-colored stools. Therefore, if a person experiences any of these symptoms, it is recommended to consult a healthcare professional for further evaluation and appropriate management.*

This is a description of a medication called Terbinafine 250mg. The pack contains 30 tablets, each of which contains Terbinafine HCI equivalent to 250mg of the cure. Manufactured by InvaGen Pharmaceuticals, Inc. and packed by Proficient Rx LP, the tablets are white, round, flat faced beveled edge and are identified with IG on one side and 209 on the other. The tablets are RX only and the lot number is 00000 with an expiry date of 00/00/00. It is recommended to store the medication at 20°-25°C (68°-77°F) and out of reach from children.*